Parkman Healthcare Partners LLC Mustang Bio, Inc. Transaction History

Parkman Healthcare Partners LLC

  • $708 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$3.01 - $3.88 $913,161 - $1.18 Million
-303,376 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$1.91 - $4.52 $2,131 - $5,044
1,116 Added 0.37%
303,376 $813,000
Q4 2019

Feb 13, 2020
BUY
$2.57 - $4.08 $776,808 - $1.23 Million
302,260 New
302,260 $1.23 Million

Others Institutions Holding MBIO

# of Institutions
2
Shares Held
415K
Call Options Held
0
Put Options Held
0
View Full List

About MUSTANG BIO, INC.

MBIO Quotes by TradingView
  • Ticker MBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,222,000
  • Market Cap $17.9M
  • Description
  • Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...
More about MBIO
Track This Portfolio

Track Parkman Healthcare Partners LLC Portfolio

Follow Parkman Healthcare Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email